SCALOP-2: A multi-centre randomised trial of induction chemotherapy followed by capecitabine plus /-nelfinavir with high or standard dose radiotherapy for locally advanced pancreatic cancer (LAPC): Results of stage 1-the non-randomised dose-finding component
Authors
Mukherjee, SVirdee, P
Shaw, R
Bridgewater, J
Radhakrishna, Ganesh
Falk, S
Scott-Brown, M
Strauss, VY
Brooks, C
Gillmore, R
Patel, N
Tranter, B
Parsons, P
Sebag-Montefiore, D
Hawkins, M
Corrie, PG
Maughan, TS
Affiliation
Oncology, Oxford Institute for Radiation Oncology, Oxford, UKIssue Date
2018
Metadata
Show full item recordCitation
Mukherjee S, Virdee P, Shaw R, Bridgewater J, Radhakrishna G, Falk S, et al. 720P SCALOP-2: A multi-centre randomised trial of induction chemotherapy followed by capecitabine +/-nelfinavir with high or standard dose radiotherapy for locally advanced pancreatic cancer (LAPC): Results of stage 1 - the non-randomised dose-finding component. Annals of Oncology. 2018;29(suppl_8).Journal
Annals of OncologyDOI
10.1093/annonc/mdy282.103PubMed ID
No PMIDAdditional Links
https://dx.doi.org/10.1093/annonc/mdy282.103Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy282.103